Empower Cervical 1/ ENGOT-Cx9/ GEICO 72-C/ GOG-3016
Trial Description:
An Open Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator’s Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Closed to Recruitment
Contact person:
aoaknin